Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 89751-89800 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05527626
Chronic Kidney Disease - REAL Life Study in Alsace
N/ARecruiting
3,000 participants
Started: Feb 17, 2022 · Completed: Aug 1, 2027
1 condition1 sponsor1 location
NCT05075980
Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study
PHASE2Recruiting
174 participants
Started: Feb 16, 2022 · Completed: Nov 15, 2035
12 conditions1 sponsor9 locations
NCT05489757
Quantitative Fluorescence Angiography With ICG for Perfusion Assessment During Surgery
NARecruiting
239 participants
Started: Feb 16, 2022 · Completed: Dec 31, 2024
4 conditions1 sponsor1 location
NCT05388487
Tolerability and Safety of HF1K16 Injection in Patients With Refractory Solid Tumors
PHASE1Recruiting
54 participants
Started: Feb 16, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors7 locations
NCT05391711
Culturally Smart Relationships Study
NAActive, not recruiting
800 participants
Started: Feb 16, 2022 · Completed: Jan 31, 2025
1 condition4 sponsors1 location
NCT05641610
A Study to Evaluate the Safety and Efficacy of ZS801 in Adult Hemophilia B Patients
PHASE1/PHASE2Recruiting
21 participants
Started: Feb 16, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05012371
Lenvatinib With Everolimus Versus Cabozantinib for Second-Line or Third-Line Treatment of Metastatic Renal Cell Cancer
PHASE2Active, not recruiting
90 participants
Started: Feb 16, 2022 · Completed: Oct 25, 2027
4 conditions2 sponsors3 locations
NCT06176300
Evaluation of Violence Prevention Strategies to Prevent and Reduce Community Levels of Youth Violence
NAEnrolling by invitation
3,390 participants
Started: Feb 16, 2022 · Completed: Mar 30, 2026
3 conditions2 sponsors1 location
NCT05277116
The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment
NAActive, not recruiting
26,877 participants
Started: Feb 16, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor12 locations
NCT05269888
Covid-19 Vaccine Immune Response in Multiple Sclerosis
N/AActive, not recruiting
240 participants
Started: Feb 16, 2022 · Completed: Dec 30, 2025
1 condition1 sponsor1 location
NCT05977088
Prediction of Effectiveness of rTMS Application in Alzheimer's Patients
NARecruiting
40 participants
Started: Feb 16, 2022 · Completed: Dec 30, 2025
1 condition3 sponsors1 location
NCT05185258
Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study
PHASE4Active, not recruiting
12 participants
Started: Feb 16, 2022 · Completed: Jul 15, 2026
5 conditions1 sponsor1 location
NCT05137119
Staphylococcus Aureus Network Adaptive Platform Trial
PHASE4Recruiting
8,000 participants
Started: Feb 16, 2022 · Completed: Dec 1, 2028
1 condition17 sponsors151 locations
NCT05165264
A Study of Nivolumab Plus Chemotherapy in First Line Treatment of Adult Participants With Advanced or Metastatic Gastric Cancer
N/AActive, not recruiting
600 participants
Started: Feb 16, 2022 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06354387
Alectinib in Combination with Nivolumab in the Treatment of Recurrent or Refractory HCC Patients Guided with Serum RNase1 and Tumor Expression of PD-L1
PHASE1Active, not recruiting
8 participants
Started: Feb 16, 2022 · Completed: Jun 1, 2026
1 condition1 sponsor1 location
NCT05122559
Neuroprotection With N-acetyl Cysteine for Patients With Progressive Multiple Sclerosis
PHASE2Recruiting
98 participants
Started: Feb 16, 2022 · Completed: Feb 28, 2027
3 conditions2 sponsors1 location
NCT05004727
Multi-Center PAMPA Study
PHASE4Recruiting
176 participants
Started: Feb 16, 2022 · Completed: Jul 31, 2028
1 condition2 sponsors5 locations
NCT04707300
Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO)
PHASE1/PHASE2Recruiting
10 participants
Started: Feb 16, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor5 locations
NCT04803747
A Trial of a Hospital Policy of Tranexamic Acid Use to Reduce Transfusion in Major Non-cardiac Surgery
PHASE4Active, not recruiting
8,440 participants
Started: Feb 16, 2022 · Completed: Oct 31, 2024
1 condition4 sponsors9 locations
NCT05695456
Targeted Elimination Diet in EoE Patients Following Identification of Trigger Nutrients Using Confocal Laser Endomicroscopy
PHASE1/PHASE2Recruiting
25 participants
Started: Feb 16, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT06353581
Prophylactic Administration of Neulapeg (Pegteograstim) in Patients With Locally Advanced or Metastatic Pancreatic Cancer Receiving the Modified FOLFIRINOX
PHASE2Active, not recruiting
78 participants
Started: Feb 16, 2022 · Completed: May 8, 2024
2 conditions1 sponsor1 location
NCT04998188
Hydrolyzed Collagen Formulation vs Placebo in Knee Osteoarthritis
NARecruiting
204 participants
Started: Feb 16, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04448184
Platelet Transfusions in Hematopoietic Stem Cell Transplantation (The PATH III Trial)
PHASE3Recruiting
662 participants
Started: Feb 16, 2022 · Completed: Feb 28, 2027
1 condition2 sponsors11 locations
NCT05421273
Effects of Active Versus Passive Recharge Burst Spinal Cord Stimulation on Pain Experience in Persistent Spinal Pain Syndrome Type 2: a Multicenter Randomized Trial (BURST-RAP Study)
NARecruiting
96 participants
Started: Feb 16, 2022 · Completed: Jun 30, 2026
2 conditions1 sponsor6 locations
NCT05117034
Pre-emptive Intravenous Morphine for Acute Post-craniotomy Pain.
NAActive, not recruiting
115 participants
Started: Feb 16, 2022 · Completed: May 1, 2025
3 conditions1 sponsor1 location
NCT05239533
Study of Nivolumab in Combination With 177Lu-girentuximab for Kidney Cancer
PHASE2Recruiting
41 participants
Started: Feb 16, 2022 · Completed: Mar 31, 2026
3 conditions1 sponsor7 locations
NCT05283850
Surviving PEA in Roanoke (SPEAR) Study
PHASE2/PHASE3Recruiting
342 participants
Started: Feb 16, 2022 · Completed: Feb 28, 2027
2 conditions2 sponsors1 location
NCT04888481
68Ga-HA-DOTATATE Imaging of Suspected Somatostatin Receptor Positive Tumors
PHASE2Recruiting
600 participants
Started: Feb 15, 2022 · Completed: Aug 31, 2028
1 condition1 sponsor1 location
NCT06126172
Radiomics of Treatment-naive Prostate Cancer Patients on Multiparametric MRI for Risk Stratification and Treatment Outcomes Predictions
NAActive, not recruiting
125 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06798805
Unraveling the Role of Extracellular Vesicles-driven Senescence in Myeloproliferative Neoplasms
N/AActive, not recruiting
110 participants
Started: Feb 15, 2022 · Completed: Aug 31, 2025
3 conditions1 sponsor5 locations
NCT05232942
Monoclonal Antibody Duration of REsponse in MIgraine After Treatment Interruption
N/ARecruiting
200 participants
Started: Feb 15, 2022 · Completed: Aug 15, 2024
2 conditions1 sponsor1 location
NCT05316740
Vaginal Microbiome and the Development of Vulvovaginal Graft Versus Host Disease
N/AActive, not recruiting
40 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT05014984
WOOP VA: Promoting Weight Management in Primary Care
NAActive, not recruiting
405 participants
Started: Feb 15, 2022 · Completed: Nov 28, 2025
1 condition2 sponsors1 location
NCT05231837
Neighborhood Park Youth Sports Program Fee Waiver and Intensive Family Outreach
PHASE3Active, not recruiting
435 participants
Started: Feb 15, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05119296
Phase II Trial of Pembrolizumab in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer
PHASE2Recruiting
20 participants
Started: Feb 15, 2022 · Completed: Nov 30, 2026
1 condition2 sponsors1 location
NCT05114278
Effect of Intravenous Iron Supplementation on Celiac Disease Remission (IRONCEL)
PHASE4Not yet recruiting
204 participants
Started: Feb 15, 2022 · Completed: Apr 15, 2026
1 condition2 sponsors1 location
NCT05210907
Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic Leukemia
PHASE1Recruiting
5 participants
Started: Feb 15, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT05241340
Neoadjuvant Sasanlimab With Radiation as an in Situ Vaccine for Cisplatin-ineligible Muscle Invasive Bladder Cancer
PHASE2Recruiting
33 participants
Started: Feb 15, 2022 · Completed: Aug 1, 2025
1 condition2 sponsors1 location
NCT05263206
Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
PHASE3Recruiting
284 participants
Started: Feb 15, 2022 · Completed: Aug 25, 2027
1 condition1 sponsor80 locations
NCT05216861
Evaluation of a Collaborative Intervention to Promote Employer Contact and RTW Among People With CMD or Chronic Pain
NARecruiting
120 participants
Started: Feb 15, 2022 · Completed: Dec 21, 2025
2 conditions2 sponsors1 location
NCT05214937
A Intervention for Reducing Sedentary Behaviour Among Prostate Cancer Survivors
NARecruiting
120 participants
Started: Feb 15, 2022 · Completed: Dec 1, 2026
2 conditions2 sponsors1 location
NCT05228262
Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis
NARecruiting
150 participants
Started: Feb 15, 2022 · Completed: Feb 1, 2027
1 condition1 sponsor1 location
NCT05255536
Effect of Different Local Anesthetic Volumes of Serratus Anterior Plan Block After Video-Assisted Thoracoscopic Surgery
NARecruiting
60 participants
Started: Feb 15, 2022 · Completed: May 15, 2024
4 conditions1 sponsor1 location
NCT05756036
Torque Teno Virus: A Biomarker of Immunosuppression
N/ARecruiting
400 participants
Started: Feb 15, 2022 · Completed: Mar 31, 2026
4 conditions1 sponsor1 location
NCT05615415
Neuropsychiatric Post-Acute Sequelae of SARS-CoV-2 (PASC) Using TSPO Positron Emission Tomography (PET) and MRI
N/AActive, not recruiting
30 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05255393
Survey on Lymphedema After Sentinel Lymph Node Biopsy in People With Cervical or Vulvar Cancer
N/ARecruiting
1,026 participants
Started: Feb 15, 2022 · Completed: Feb 28, 2026
2 conditions1 sponsor1 location
NCT05493813
Total Intravenous Anesthesia Versus Sevoflurane Anesthesia for Endovascular Thrombectomy in Acute Ischemic Stroke
NARecruiting
298 participants
Started: Feb 15, 2022 · Completed: Dec 30, 2025
6 conditions1 sponsor1 location
NCT04902508
Evaluation of an Explicit Approach
NARecruiting
200 participants
Started: Feb 15, 2022 · Completed: May 31, 2026
3 conditions1 sponsor1 location
NCT05165160
Residual Disease Evaluation of Resected NSCLC by cirDNA Analysis
NAActive, not recruiting
133 participants
Started: Feb 15, 2022 · Completed: Jul 15, 2025
1 condition1 sponsor1 location
NCT05239143
P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
PHASE1Active, not recruiting
180 participants
Started: Feb 15, 2022 · Completed: Apr 30, 2039
9 conditions1 sponsor14 locations